| Views | |
|---|---|
| Development of a transcutaneous form of desloratadine | 48 |
| April 2025 | May 2025 | June 2025 | July 2025 | August 2025 | September 2025 | October 2025 | |
|---|---|---|---|---|---|---|---|
| Development of a transcutaneous form of desloratadine | 1 | 5 | 2 | 4 | 0 | 8 | 8 |
| Views | |
|---|---|
| Ageev_Development_24.pdf | 28 |
| Views | |
|---|---|
| United States | 17 |
| EU | 3 |
| India | 3 |
| Germany | 2 |
| Russia | 2 |
| Australia | 1 |
| Brazil | 1 |
| Canada | 1 |
| China | 1 |
| Jordan | 1 |
| Views | |
|---|---|
| Mountain View | 9 |
| Mumbai | 3 |
| Sacramento | 3 |
| Palo Alto | 2 |
| Amman | 1 |
| Beijing | 1 |
| Dearborn | 1 |
| Englewood | 1 |
| Haugesund | 1 |
| Mytishchi | 1 |